In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Keranova gets €24mm in second round

Executive Summary

Keranova (ophthalmic surgical devices) raised €24mm ($26.5mm) in its second financing to returning shareholders Mérieux Equity Partners and Supernova Invest and first-time backers Financière Arbevel, Tourrette Investissement, and other international partners. The company will use the funds to gain the CE Mark for its ultra-fast robotized ophthalmology laser for cataract surgery.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies